
Windlas Biotech Ltd is Rated Hold by MarketsMOJO
2026-11-17 10:11:07Windlas Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 Nov 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreWindlas Biotech Surges 13.45% in a Week: Key Momentum Shifts and Market Dynamics
2026-11-07 12:02:42Key Events This Week 2 Nov: Technical momentum shifts amid mixed market signals 3 Nov: Mildly bullish momentum emerges with cautious optimism 5 Nov: Technical momentum shifts to sideways trend 6 Nov: Intraday high surge of 8.52% with strong volume 6 Nov: Technical momentum shifts to mildly bullish amid mixed indicators Week OpenRs.877.25 ...
Read More
Windlas Biotech Ltd is Rated Hold by MarketsMOJO
2026-11-06 10:11:34Windlas Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 November 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Windlas Biotech Ltd Technical Momentum Shifts Amid Sideways Trend
2026-11-05 08:06:35Windlas Biotech Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a modest decline in price, the stock’s technical indicators reveal a complex interplay of bearish and bullish signals, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.
Read MoreWindlas Biotech Gains 0.58%: Mixed Technical Signals and Downgrade Shape Weekly Moves
2026-10-31 12:02:10Key Events This Week 26 Oct: Mojo Score downgraded to Sell amid technical weakness and flat financials 27 Oct: Technical momentum shifts to mildly bullish with mixed indicator signals 29 Oct: Technical trend shifts back to sideways despite daily gains 30 Oct: Mildly bullish momentum emerges with 3.73% daily gain 30 Oct: Week closes at ₹877.25 (+0.58%) Week Open<div class="stat-valu...
Read More
Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-30 08:02:35Windlas Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, the stock’s technical indicators present a mixed picture, with some signals suggesting caution while others hint at potential upside. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term prospects.
Read More
Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-29 08:03:02Windlas Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Recent technical indicators reveal a transition from a mildly bullish trend to a sideways movement, prompting a downgrade in its Mojo Grade from Hold to Sell as of 23 Oct 2026.
Read More
Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-27 08:06:38Windlas Biotech Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive tilt, the company’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, reflecting cautious optimism amid ongoing market volatility.
Read More
Windlas Biotech Ltd Faces Technical Momentum Shift Amid Market Volatility
2026-10-26 08:02:53Windlas Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish trend to a sideways movement. The stock’s recent performance, combined with mixed signals from MACD, RSI, and moving averages, suggests a period of consolidation amid broader market volatility.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
13-Nov-2026 | Source : BSEQ2 & H1 FY27 Earnings Conference Call Transcript
Recording Of Conference Call
06-Nov-2026 | Source : BSERecording of Conference Call
Announcement under Regulation 30 (LODR)-Investor Presentation
05-Nov-2026 | Source : BSEInvestor Presentation - Q2 & H1FY27
Corporate Actions
No Upcoming Board Meetings
Windlas Biotech Ltd has declared 126% dividend, ex-date: 16 Jul 26
No Splits history available
No Bonus history available
No Rights history available